A Real Utility Token Used in Clinical Trials, Research, and Medical Product Payments
GDT is already accepted as payment for diabetes cure treatment tours, online diagnostics, and biomarker tests, as well as 5-ALA-based drugs and supplements. Every use supports ongoing clinical trials, with 20% of used tokens burned to reduce supply.
What is Diabetes?
Diabetes affects over 590 million people and costs $1 trillion annually—making it one of the world’s most urgent health challenges.
Abnormal stem cells (diabetes stem cells, or DSCs) are a cause of diabetes.
Diabetes Can Be Cured.
Proof of Cure
We have entered the phase of proving the world’s first complete remission for diabetes. With more than 20 years of research, a Phase IIa trial for 5-ALA, international patents, and compelling human data.
How GDT Works:
“Real-World Utility That Drives Real-World Change.”
GDT is more than just a token—it’s the key to accessing life-changing medical services. From paying for curative diabetes treatments and diagnostic tests to receiving online consultations and participating in research, GDT powers a complete ecosystem of healthcare innovation. With every use, 20% of tokens are burned, reducing supply and increasing long-term value.
Diabetes Cure Tour 〈Priority for Investors〉
The high-end medical tour aimed at complete remission through mid- to long-term stays is an exclusive utility for investors. Priority access to consultations with specialist physicians is included. 20% of the tokens used for payment will be burned, reducing the total supply.
Payment Method for Medical Tourism
GDT can be used for all payments related to medical tourism services in the UAE, Palau, and Japan. As the medical tourism market continues to grow, GDT meets the payment needs of international patients.
Purchase of 5-ALA Products and Supplements
GDT can be used to purchase 5-ALA formulations and supplements. This utility supports patient safety and continued use during and after treatment.
Payment for Diabetic Stem Cell Biomarker Testing
GDT can be used to pay for biomarker testing that identifies abnormal stem cells (DSCs). These tests are essential for early detection and treatment selection, providing strong, stable demand for the token.
Token Allocation
Cure Business
This project aims to raise USD 20–30 million within the first six months after the TGE. This will secure bridge funding from the Palau clinical trial to the UAE Phase III application and simultaneously onboard first medical tourism users (investor-tier participants).
Token Demand & Supply
Real-World Use, Sustainable Circulation
GDT creates natural demand through real-world use cases—medical tourism, diagnostics, and product purchases—while a fixed supply and burn mechanism ensure long-term sustainability. The more it’s used, the rarer it becomes.
Tokenomics & Roadmap:
Fueling the Cure, Step by Step
GDT powers every phase of our mission—from clinical trials to medical tourism—through a fixed supply, transparent allocation, and real-world utility. Our roadmap charts a global rollout of curative solutions, turning vision into action.
Tokenomics
“Transparent, Finite, Purpose-Driven.”
GDT has a fixed supply of 500 million tokens—no inflation, no dilution. Every allocation supports real-world utility: investors, services, rewards, liquidity, and global health equity.
GDT will be offered through four structured sale phases, starting at a discounted rate for early supporters. With each phase, the price increases by 15%, rewarding early participation and supporting project milestones with transparent, capped token supply.
What We Have Achieved So Far
Two Decades of Scientific Breakthroughs
GDT has a fixed supply of 500 million tokens—no inflation, no dilution. Every allocation supports real-world utility: investors, services, rewards, liquidity, and global health equity.
Roadmap for 2025 and Beyond
Scaling from Proof to Global Impact
Starting with trials in Palau, we will expand to the UAE, Japan, and the U.S., aiming for regulatory approvals and a full-scale launch of curative therapies by 2030. Our step-by-step roadmap aligns token utility with clinical progress to build a global cure ecosystem.
